Title:
IMIDAZOTRIAZINE DERIVATIVES AS CD73 INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2020/210970
Kind Code:
A1
Abstract:
The present disclosure relates generally to imidazotriazine derivatives that are inhibitors of CD73 and are useful in treating CD73-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.
More Like This:
Inventors:
BAILEY SIMON (US)
CHEN DIANJUN (CN)
FENG JIANXIA (CN)
KAYSER FRANK (US)
LIU CHONG (CN)
YUAN HONGBIN (CN)
CHEN DIANJUN (CN)
FENG JIANXIA (CN)
KAYSER FRANK (US)
LIU CHONG (CN)
YUAN HONGBIN (CN)
Application Number:
PCT/CN2019/082816
Publication Date:
October 22, 2020
Filing Date:
April 16, 2019
Export Citation:
Assignee:
BIOARDIS LLC (US)
BAILEY SIMON (US)
CHEN DIANJUN (CN)
FENG JIANXIA (CN)
KAYSER FRANK (US)
LIU CHONG (CN)
YUAN HONGBIN (CN)
BAILEY SIMON (US)
CHEN DIANJUN (CN)
FENG JIANXIA (CN)
KAYSER FRANK (US)
LIU CHONG (CN)
YUAN HONGBIN (CN)
International Classes:
C07H19/16; A61K31/70; A61K31/7052; A61K31/7076; A61P35/00; C07H19/20; C07H19/207
Domestic Patent References:
WO2017120508A1 | 2017-07-13 |
Foreign References:
US6326490B1 | 2001-12-04 |
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF:
Previous Patent: ENDOSCOPIC SYSTEMS, DEVICES, AND METHODS
Next Patent: CONTROLLING TRANSMITTER OUTPUT
Next Patent: CONTROLLING TRANSMITTER OUTPUT